T.B. is a 32-year-old woman who is enrolled in a worksite smoking-cessation program.
During the previous group session, the cessation counselor discussed the various medications for cessation.
T.B. has set her quit date for 1 week from today, and she is interested in starting the nicotine transdermal patch.
She is currently smoking 1.5 packs per day (PPD), which is a reduction from the 2 PPD she had been smoking for the past 10 years.
T.B. reports she smokes several cigarettes in succession immediately after waking in the morning.
She takes no medications and has no medical problems.

QUESTION:
Which nicotine transdermal product should T.B. select, and how should it be used?
